Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat - A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

Author： Bymaster F.P.   Katner J.S.   Nelson D.L.   Hemrick-Luecke S.K.   Threlkeld P.G.   Heiligenstein J.H.   Morin S.M.   Gehlert D.R.   Perry K.W.  

Publisher： Elsevier

ISSN： 0893-133X

Source： Neuropsychopharmacology, Vol.27, Iss.5, 2002-11, pp. : 699-711

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Spotlight on Atomoxetine in Adults with Attention-Deficit Hyperactivity Disorder

By Simpson D.   Plosker G.L.  

CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 397-401

Adis International

Access to resources Recommend Favorite

Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents—meta-analysis and meta-regression analysis

By Cheng Jackie   Chen Ronald   Ko John   Ng Emil  

Psychopharmacology, Vol. 194, Iss. 2, 2007-10 ,pp. : 197-209

Springer Publishing Company

Access to resources Recommend Favorite

Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine

By Ramos-Quiroga Josep   Corominas-Roso Margarida   Palomar Gloria   Gomez-Barros Nuria   Ribases Marta   Sanchez-Mora Cristina   Bosch Rosa   Nogueira Mariana   Corrales Montserrat   Valero Sergi   Casas Miguel  

Psychopharmacology, Vol. 231, Iss. 7, 2014-04 ,pp. : 1389-1395

Springer Publishing Company

Access to resources Recommend Favorite

Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents†

By Garnock-Jones Karly P.   Keating Gillian M.  

CNS Drugs, Vol. 24, Iss. 1, 2010-01 ,pp. : 85-88

Adis International

Access to resources Recommend Favorite

Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder

By Stiefel Gary  

Drug Safety, Vol. 33, Iss. 10, 2010-10 ,pp. : 821-842

Adis International

Access to resources Recommend Favorite